Cyclerion Therapeutics In...
3.00
0.08 (2.74%)
At close: Jan 15, 2025, 3:59 PM
3.01
0.40%
After-hours Jan 15, 2025, 04:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
PE Ratio -0.37 -0.65 -1.3 -1.28 -0.62 -2.96 -3.63 -5.39
PS Ratio n/a 95.99 20.28 40.52 16.52 n/a n/a n/a
PB Ratio 0.69 2.73 1.40 1.56 0.76 -32.68 -39.84 n/a
P/FCF Ratio -0.37 -0.7 -1.84 -1.26 -0.68 -3.38 -4.13 -6.67
P/OCF Ratio -0.37 -0.7 -1.84 -1.28 -0.73 -3.5 -4.2 -6.87
OCF/S Ratio n/a -136.74 -11 -31.57 -22.68 n/a n/a n/a
Debt / Equity Ratio n/a n/a n/a 0.77 0.76 n/a n/a n/a
Quick Ratio 3.85 1.84 4.92 3.40 5.44 0.05 0.09 n/a
Current Ratio 3.85 1.94 5.00 3.45 5.55 0.05 0.09 n/a
Asset Turnover n/a 0.02 0.06 0.02 0.02 n/a n/a n/a
Interest Coverage n/a -150.93 -3.45K n/a n/a n/a n/a n/a
Return on Equity (ROE) -1.86 -4.19 -1.07 -1.22 -1.24 11.03 10.96 n/a
Return on Assets (ROA) -1.57 -2.42 -0.87 -0.63 -0.65 -15.57 -17.17 n/a
Return on Capital (ROIC) -0.85 -4.25 -1.14 -0.83 -0.74 11.03 10.96 n/a
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a 78.11% 85.78% 100.00% 100.00% n/a n/a n/a
Net Profit Margin n/a -14.74K% -1.56K% -3.17K% -2.68K% n/a n/a n/a
Pretax Profit Margin n/a -14.84K% -1.56K% -3.39K% -2.73K% n/a n/a n/a
Operating Profit Margin n/a -14.94K% -1.66K% -3.54K% -2.77K% n/a n/a n/a
FCF Margin n/a -13.67K% -1.10K% -3.22K% -2.42K% n/a n/a n/a
EBITDA Margin n/a -6.12K% -1.66K% -3.54K% -2.71K% n/a n/a n/a